Evaluation of usability, adherence, and clinical efficacy of therapeutic footwear in persons with diabetes at moderate to high risk of diabetic foot ulcers: A multicenter prospective study.

OBJECTIVE: To evaluate therapeutic footwear expectations and usability of individuals with diabetes and foot complications. DESIGN: A prospective multicenter study was conducted on participants with a high risk of developing a diabetic foot ulcer. SETTING: Participants were enrolled in 11 different specialized diabetic foot units in Spain between March 2022 and June 2023. SUBJECTS: Patients with diabetes at moderate to high risk of foot ulceration receiving first therapeutic footwear prescription. INTERVENTIONS: All the patients included in the research were prescribed with their first pair of therapeutic footwear. MAIN MEASURES: Primary outcome measures were MOS-pre and MOS-post questionnaires evaluating use and usability of prescribed therapeutic footwear. Secondary outcome measures aimed to evaluate footwear clinical efficacy as ulceration rate and self-reported perceived walking distance per day. RESULTS: The use of therapeutic footwear exceeded the patient's pre-provision prediction of their anticipated use in 94% of people (n = 126). Based on the visual analogic satisfaction scale, the median satisfaction of daily wearing their therapeutic footwear was 7 points, Interquartile Range (IQR) [5-8.25]. During the follow-up period, 39 participants (29.1%) experienced diabetic foot ulcer. Perceived walking distance participants reported an improvement in their perceived walking ability during various daily life activities. CONCLUSIONS: Diabetes patients at moderate to high risk of diabetic foot ulcer improved their perception of walking ability after therapeutic footwear prescription. Adherence to the therapeutic footwear prescription resulted in less ulcerations.

[Activated carbon and silver biocide dressings for diabetic foot. A descriptive analysis]. / Mallas biocidas de carbono activo y plata en el pie diabético. Análisis descriptivo.

Bacterial colonization without clinical signs of infection has been established as a cause in the delay of the cicatrisation process of diabetic foot ulcers; therefore, among other factors, it is necessary to control the bacterial amount present. One method to carry out this control consists in applying local biocide dressings. To evaluate its safety and effectiveness, the authors have gathered data from a sample of patients suffering from ulcers which have a positive microbiological culture but do not show any complementary complications such as osteomyelitis, severe infection in soft tissues, ischemic necrosis infection, and whose local treatment during 15 days following the positive culture taken at the lesion consisted of the application of the aforementioned biocide dressings. A total of 68 patients have been included in this sample.

Mallas biocidas de carbono activo y plata en el pie diabético / Activated carbon and silver biocide dressing for diabetic foot a descriptive analysis

La colonización bacteriana sin signos clínicos de infección ha sido establecida como causa del retraso en la cicatrización de las úlceras de pie diabético: por tanto, será necesario, entre otros muchos factores, controlar la carga bacteriana. Una forma de realizar este control consiste en aplicar localmente mallas biocidas. Para evaluar su seguridad y su eficacia se han recogido datos de una muestra de pacientes ulcerados, con cultivo microbiológico positivo, que no presenten complicaciones añadidas: osteomielitis, infección severa de partes blandas, infección necrosante e isquemia, y cuyo tratamiento local durante los 15 días posteriores al cultivo positivo de la lesión consistiera en la aplicación de dichas mallas biocidas. Se incluye un total de 68 pacientes(AU)

Bacterial colonization without clinical signs of infection has been established as a cause in the delay of the cicatrisation process of diabetic foot ulcers; therefore, among other factors, it is necessary to control the bacterial amount present. One method to carry out this control consists in applying local biocide dressings. To evaluate its safety and effectiveness, the authors have gathered data from a sample of patients suffering from ulcers which have a positive microbiological culture but do not show any complementary complications such as osteomyelitis, severe infection in soft tissues, ischemic necrosis infection, and whose local treatment during 15 days following the positive culture taken at the lesion consisted of the application of the aforementioned biocide dressings. A total of 68 patients have been included in this sample(AU)